Mayo Clinic ‘cautiously optimistic’ on Biogen’s Alzheimer’s drug
July 06, 2018 at 16:15 PM EDT
The latest clinical trial results for an Alzheimer’s treatment from drugmakers Biogen and Eisai are “early but encouraging,” says the Mayo Clinic’s Ronald Peterson.
